Concepedia

Haley Howell

HH

Statistics

Publications

2

Citations

23

H-Index

2

Active since

2018

Affiliations

480 Biomedical (United States)(Current)

Haley Howell is an author at 480 Biomedical (United States) specializing in oncology, cancer research, and radiation oncology.

Top concepts

Publications per year

2018–2024

2

Publications

2

First‐in‐Human Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of DISC‐0974, an Anti‐Hemojuvelin Antibody, in Healthy Participants

Natasha Novikov, Akshay Buch, Hua Yang et al. · The Journal of Clinical Pharmacology · 2024 · 12 citations · Full text

Interim Update from a Phase 2 Multicenter Study of Tazemetostat, an EZH2 Inhibitor, in Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

John M. Pagel, Franck Morschhauser, Tilly Herve et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 11 citations

, , +8

1–2 of 2